Oppenheimer Cuts Price Target Following Derma Sciences' (DSCI) 4Q Preliminary Results
Tweet Send to a Friend
Oppenheimer maintained an Outperform rating on Derma Sciences (NASDAQ: DSCI), and cut the price target to $7.00 (from $8.00), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
